前列腺癌非脊柱骨转移立体定向放疗临床靶区勾画者间变异:CT、MRI与PET/CT融合
本研究选取本中心13例患者的15处转移灶,由4名观察者分别在单独计划CT、计划CT+MRI融合、计划CT+PET-CT融合及计划CT+MRI+PET-CT融合上独立勾画临床靶区。结果显示计划CT+MRI+PET-CT融合勾画的平均CTV体积显著大于其他模态,计划CT+PET-CT与计划CT+MRI+PET-CT的观察者间一致性最高。
要点
- 计划CT+MRI+PET-CT融合勾画的平均CTV体积显著大于其他成像模态(p=0.0001)。
- 计划CT+PET-CT融合(平均CIgen 0.55,范围0.32-0.73)与计划CT+MRI+PET-CT融合(平均CIgen 0.59,范围0.34-0.73)观察者间一致性最高。
- dCOM在各成像模态间变化小,但计划CT+PET-CT较计划CT+PET-CT+MRI联合显著更短(p=0.03)。
核心结论
- 观察者间CTV勾画一致性最高见于计划CT+PET-CT融合与计划CT+PET-CT+MRI联合融合。
研究设计与样本
- 本研究选取本中心13例患者的15处前列腺癌非脊柱骨转移灶,由4名观察者独立勾画。
- 观察者分别在单独计划CT、计划CT+MRI融合、计划CT+PET-CT融合及计划CT+MRI+PET-CT融合上勾画临床靶区。
- 按每处转移灶和每种成像模态计算勾画体积、广义一致性指数(CIgen)和质心距离(dCOM)以比较观察者间一致性。
主要发现
- 计划CT+MRI+PET-CT融合勾画的平均CTV体积显著大于其他成像模态(p=0.0001)。
- CIgen在各模态间差异明显,计划CT+PET-CT融合平均CIgen为0.55(范围0.32-0.73),计划CT+MRI+PET-CT融合平均CIgen为0.59(范围0.34-0.73)。
- dCOM在各成像模态间变化小,但计划CT+PET-CT较计划CT+PET-CT+MRI联合显著更短(p=0.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The use of SBRT for the treatment of oligometastatic prostate cancer is increasing rapidly. While consensus guidelines are available for non-spinal bone metastases practice continues to vary widely. The aim of this study is to look at inter-observer variability in the contouring of prostate cancer non-spinal bone metastases with different imaging modalities. MATERIALS AND METHODS: 15 metastases from 13 patients treated at our centre were selected. 4 observers independently contoured clinical target volumes (CTV) on planning CT alone, planning CT with MRI fusion, planning CT with PET-CT fusion and planning CT with both MRI and PET-CT fusion combined. The mean inter-observer agreement on each modality was compared by measuring the delineated volume, generalized conformity index (CIgen), and the distance of the centre of mass (dCOM), calculated per metastasis and imaging modality. RESULTS: Mean CTV volume delineated on planning CT with MRI and PET-CT fusion combined was significantly larger compared to other imaging modalities (p = 0.0001). CIgen showed marked variation between modalities with the highest agreement between planning CT + PET-CT (mean CIgen 0.55, range 0.32-0.73) and planning CT + MRI + PET-CT (mean CIgen 0.59, range 0.34-0.73). dCOM showed small variations between imaging modalities but a significantly shorter distance found on planning CT + PET-CT when compared with planning CT + PET-CT + MRI combined (p = 0.03). CONCLUSIONS: Highest consistency in CTV delineation between observers was seen with planning CT + PET-CT and planning CT + PET-CT + MRI combined.
引用
- Chapman ER, Nicholls L, Suh YE, et al. Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusion. Radiother Oncol. 2023. PMID: 36634852. doi:10.1016/j.radonc.2022.109461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。